COMP <GO>
KTTA vs JAGX // RETURN ON INVESTED CAPITAL (ROIC)
Pasithea Therapeutics Corp. (NASDAQ) VS. Jaguar Health Inc. (NASDAQ) • 15-METRIC TALLY: KTTA 1
— JAGX 2
■ METRIC PARITY
LAST: $0.37 (-0.59%) • MKT CAP: $12.4M
roic
-35.00%
LAST: $0.88 (-45.43%) • MKT CAP: $12.6M
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KTTA VS. JAGX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KTTA | JAGX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 67.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -0.50% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -1.50% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 1/9 | +1.00 | KTTA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.2 | 40.2 | -6.00 | JAGX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.4M | $12.6M | -$269.4K | JAGX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KTTA REV | JAGX REV | KTTA GROSS % | JAGX GROSS % | KTTA FCF | JAGX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $58.4M | $11.5M | — | 67.2% | -$15.2M | -$23.7M |
| FY 2024 | $39.9M | $11.7M | — | 83.3% | -$13.9M | -$29.4M |
| FY 2023 | $44.7M | $9.8M | — | — | — | -$33.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KTTA // BETA —
JAGX // BETA —